Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
作者信息
Post S G, Beerman B, Brodaty H, Gaines A W, Gauthier S G, Geldmacher D S, Hill S, Homma A, Rossor M N, Whitehouse P J, Winblad B
机构信息
Center for Biomedical Ethics, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
出版信息
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:26-8.
PMID:9305511
Abstract
摘要
相似文献
1
Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:26-8.
2
Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:39-45.
3
Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:34-8.
4
Translation issues in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:61-4.
5
Clinical trials of treatment for noncognitive symptoms of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:54-5.
6
Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:6-7.
7
Cultural issues in the clinical diagnosis of Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:19-21.
8
Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:22-5.
9
Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:46-9.
10
length of clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:33.
Zotero 插件